卡博替尼 (S)-苹果酸盐

卡博替尼 (S)-苹果酸盐（CAS 1140909-48-3）的公开数据库记录，列此仅供独立核对。

危险化学品分类与危害说明

这个物质在各数据库里的编号

数据库记载的用途

• Cabometyx (Cabozantinib-S-Malate)
• Cabozantinib-s-malate is approved to treat:
• • Differentiated thyroid cancer that has spread. It is used in adults and children aged 12 years and older who cannot receive radioactive iodine and whose cancer got worse after VEGFreceptor-targeted therapy. This use is approved for the Cabometyx brand of cabozantinib-s-malate.
• • Hepatocellular carcinoma (a type of liver cancer). It is used in patients who have already been treated with sorafenib. This use is approved for the Cabometyx brand of cabozantinib-s-malate.
• • Medullary thyroid cancer that has gotten worse and has spread to other parts of the body. This use is approved for the Cometriq brand of cabozantinib-s-malate.
• • Neuroendocrine tumor of the pancreas or another organ that is well-differentiated, has spread, and cannot be removed by surgery. It is used in adults and children aged 12 years and older whose cancer has been treated. This use is approved for the Cabometyx brand of cabozantinib-s-malate.

它在各数据库里的别名

Cabozantinib S-malate; 1140909-48-3; Cabozantinib malate; cabozantinib (S)-malate; Cabometyx; XL184; DR7ST46X58; CHEBI:72319; DTXSID60915949; RefChem:1080604; DTXCID501510465; Cabozantinib malate (XL184); Cabozantinib (S-malate); Cabozantinib L-Malate Salt; MFCD20923480; Cabozantinib s-malate [USAN]

计算机算出的分子描述符

数据库摘要

cabozantinib (S)-malate · CAS 1140909-48-3 · C32H30FN3O10. UNII DR7ST46X58.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。